We are live on ! Find out more
KEQU icon

Kewaunee Scientific

19 hedge funds and large institutions have $27.8M invested in Kewaunee Scientific in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more capital invested

Capital invested by funds: $16.2M → $27.8M (+$11.6M)

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

0.63% more ownership

Funds ownership: 32.6%33.23% (+0.63%)

0% more funds holding

Funds holding: 1919 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
19
Holders Change
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
6
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

KEQU Hedge Fund Activity: Q4 2023 in Review

19 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Kewaunee Scientific (KEQU) for Q4 2023, worth a combined $27.8M — up 71% from $16.2M a quarter earlier.

Fund positioning in KEQU was balanced in Q4 2023: 1 fund opened new positions, 1 closed out, 6 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $473K. The largest seller was Northern Trust, cutting an estimated $65.8K.

  • 19 institutional investors held Kewaunee Scientific (KEQU) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $27.8M of Kewaunee Scientific stock for Q4 2023, up 71% quarter-over-quarter.
  • 1 fund opened new Kewaunee Scientific positions in Q4 2023 and 1 closed out, a net change of 0 holders.
  • The largest Kewaunee Scientific buyer in Q4 2023 was Morgan Stanley, an estimated $473K added.
  • The largest Kewaunee Scientific seller in Q4 2023 was Northern Trust, an estimated $65.8K sold.

Based on aggregated 13F filings for Q4 2023.